Tevogen Bio Holdings Inc. (TVGN): AI Innovations in Immunotherapy
We recently published a list of Complete List of All AI Companies Under $2 Billion Market Cap. In this article, we are going ...
The American Journal of Managed Care57m
Adjuvant Cemiplimab Significantly Improves Disease-Free Survival in High-Risk Skin Cancer
Cemiplimab significantly reduced the risk of recurrence or death in patients with high-risk cutaneous squamous cell carcinoma ...